Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2024-08-22 Regulatory Filings
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Warunkowa decyzja Państwowego Urzędu Własności Intelektualnej Chin o przyznaniu patentu w ramach projektu BACTEROMIC - Content (PL)
Regulatory Filings Classification · 100% confidence The document text, written in Polish, discusses a conditional decision by the Chinese State Intellectual Property Office to grant a patent to a subsidiary (Bacteromic) for a microfluidic chip geometry used in microbiological testing. It details the implications of the patent (exclusivity for commercial use) and mentions that similar patents are already in force in European Patent Convention countries and that a conditional decision was also received from the US Patent and Trademark Office. This content relates to intellectual property rights and technological developments, which falls under the scope of general corporate disclosures, but is not explicitly covered by the specific categories like 10-K, ER, or DIV. Since it is a specific announcement regarding a legal/IP development (patent grant), it is best classified as a general Regulatory Filing (RNS) as it doesn't fit the more specific categories like LTR (Legal Proceedings Report, which usually implies litigation) or CAP (Financing). Given the nature of the announcement (patent grant), RNS is the most appropriate fallback for a significant, non-financial, non-management specific regulatory event.
2024-08-22 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu Spółki, które odbyło się w dniu 25 czerwca 2024 r.
Major Shareholding Notification Classification · 99% confidence The document text is a table listing shareholders who held at least 5% of the votes at the Annual General Meeting (Zwyczajne Walne Zgromadzenie) held on June 25, 2024. This directly relates to the official results of a shareholder vote. The definition for Declaration of Voting Results & Voting Rights Announcements (DVA) is: 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Although the document is a list of major shareholders present/voting, it is a direct output/result of the voting process at the AGM, making DVA the most appropriate classification.
2024-06-28 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu Spółki, które odbyło się w dniu 25 czerwca 2024 r. - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (218 characters) and states that the Management Board ('Zarząd') is attaching a list of shareholders who held at least 5% of the votes at the Ordinary General Meeting ('Zwyczajnym Walnym Zgromadzeniu') held on June 25, 2024. This content relates directly to the results or participants of a shareholder meeting. Since it is an announcement providing specific data related to a general meeting, and not the full presentation (AGM-R) or the formal voting results declaration (DVA), it is most closely related to shareholder/meeting information. Given the options, the most appropriate classification for a specific announcement related to a General Meeting's outcome data, especially when it's a short notification, is often DVA (Declaration of Voting Results & Voting Rights Announcements) or potentially RNS if it's a general regulatory disclosure. However, since it explicitly details shareholder voting power at the AGM, DVA is the most specific fit for the content described, even if it's not the final tally. If DVA is too strict, RNS is the fallback. Given the context of reporting shareholder voting percentages immediately following an AGM, DVA is the intended category for such disclosures.
2024-06-28 Polish
Informacje dot.Patryka Mikuckiego
Board/Management Information Classification · 98% confidence The document provides detailed biographical information, professional history, qualifications, and potential conflicts of interest (or lack thereof) for an individual named Patryk Mikucki, specifically focusing on his background in R&D and Clinical Research within the pharmaceutical industry (Alexion, AstraZeneca). This type of disclosure, detailing the background of a newly appointed or existing board member/senior executive, strongly aligns with the requirements for reporting management or board changes. This fits the definition of Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings announcement (ER), or a proxy statement (DEF 14A/PSI).
2024-06-25 Polish
Powołanie członka Rady Nadzorczej - Content (PL)
Board/Management Information Classification · 98% confidence The document text, written in Polish, announces that the Ordinary General Meeting (Zwyczajne Walne Zgromadzenie) appointed Mr. Patryk Mikucki to the Supervisory Board (Rada Nadzorcza) for another term on June 25, 2024. This directly relates to changes in the company's board of directors or senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The document is very short and mentions that the information about the person is an attachment, but the core content is the management change announcement itself, making MANG a better fit than RPA or RNS.
2024-06-25 Polish
Treść uchwał podjętych przez ZWZ Spółki w dniu 25 czerwca 2024 r.
AGM Information Classification · 100% confidence The document text consists entirely of numbered resolutions ("UCHWAŁA NR X") passed by the "Zwyczajnego Walnego Zgromadzenia" (Ordinary General Meeting) of Scope Fluidics S.A. on June 25, 2024. These resolutions cover the approval of the agenda, approval of annual reports (including financial statements for the year ended December 31, 2023), approval of the Supervisory Board's report, and the granting of discharge (absolutorium) to management and supervisory board members for their duties during that year. This content is the core documentation resulting from an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2024-06-25 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.